Diphtheria & Tetanus Toxoids & Pertussis Vaccine Adsorbed
Status: withdrawn from the U.S. market
Organizations involved:
BioPort Corp. – Manuf.; R&D; Tech.; Former
Emergent BioSolutions Inc. – Parent; Former
Michigan Biologics Products Institute – Former
Cross ref: See the entries for component vaccines – Tetanus Toxoid Adsorbed (#551), Diphtheria Toxoid Adsorbed (#419), and Pertussis Vaccine Adsorbed (#510), from BioPort Corp. See the entries for Diphtheria and Pertussis Toxoids and Pertussis Vaccine (DTP/DTaP) Products (#429); Tetanus Toxoid Products (#543); and Diphtheria Toxoid Products (#418).
Description: This was a DTP vaccine manufactured by the Michigan Biologics Products Institute (MBPI), which became BioPort Corp., which later became a subsidiary of Emergent BioSolutions Inc. MBPI/BioPort held only a very small market share for DTP vaccines.
Nomenclature: DTP Vaccine/BioPort [BIO]; Diphtheria & Tetanus Toxoids & Pertussis Vaccine Adsorbed [FDA]; Diphtheria & Tetanus Toxoids & Pertussis Vaccine Aluminum Phosphate Adsorbed [FDA former]; DTP Vaccine [SY]
Companies.: Diphtheria & Tetanus Toxoids & Pertussis Vaccine Adsorbed was manufactured by BioPort Corp. (formerly Michigan Biologics Products Institute; before that, Michigan Department of Public Health, now part of Emergent BioSolutions Inc.), FDA CBER est. no. 0099.
FDA class: Biologic PLA
CBER class: Multiple Antigen Preparations
Approvals: Date = unknown; original approval date not available from FDA
Date = 19700827; first approval granted to Michigan Department of Public Health, according to the CBER BRMS database. However, an FDA letter to the company on this date states that approval was revoked and granted (reissued) using a new (the current) proper name, i.e., it was renamed Diphtheria & Tetanus Toxoids & Pertussis Vaccine Adsorbed
Date = 19981112; licenses (PLA/ELA) revoked from Michigan Biologics Products Institute and granted (reissued) to new owner, BioPort Corp.
Date = 20001020; license voluntarily revoked
Indications: product insert/labeling not available
Status: The product is no longer approved, manufactured, or marketed. Voluntary license revocation was reported in the Federal Register, May 29, 2001, vol. 66, no. 103, p. 29148-9.
Companies involvement:
Full monograph
448 DTP Vaccine/BioPort
Nomenclature:
DTP Vaccine/BioPort [BIO]
Diphtheria & Tetanus Toxoids & Pertussis Vaccine Adsorbed [FDA]
Diphtheria & Tetanus Toxoids & Pertussis Vaccine Aluminum Phosphate Adsorbed [FDA former]
DTP Vaccine [SY]
FDA Class: Biologic PLA
Year of approval (FDA) = 1970
Date of 1st FDA approval = 19700827
(in format YYYYMMDD)
Index Terms:
biopharmaceutical products
vaccines, bacterial
vaccines, combination
vaccines, toxoids (inactivated toxins)
bacterial culture <!-- bacterialculture -->
Bordetella pertussis
Clostridium tetani
Corynebacterium diphtheriae
Diphtheria Toxoid
formaldehyde
Pertussis Vaccine Adsorbed
Tetanus Toxoid
approval dates uncertain (FDA reports erroneous, conflicting, or simply has lost the original approval dates) (FDAapproved)
approval dates uncertain (FDA reports erroneous, conflicting, or simply has lost the original approval dates) (FDAapproved)
approval dates uncertain (FDA reports erroneous, conflicting, or simply has lost the original approval dates) (FDAapproved)
approval dates uncertain (FDA reports erroneous, conflicting, or simply has lost the original approval dates) (FDAapproved)
North American coral snake
North American coral snake
EU011 Approved Formerly in EU/withdrawn
UM999 Not Available/Not Marketed in US
US011 Approved Formerly in US/withdrawn
EM999 Not Available/Not Marketed in EU
Copyright© 2020, Biotechnology Information Institute